The company's intellectual property intelligence platform delivers a full, multi-level understanding of the targeted IP space, identifying valuable opportunities and hidden threats in molecular science. Accencio offers interactive tools, analysis, consulting, and partner engagement services to provide vital and novel insight and support to get intellectual property rights. Its cloud-based, subscription products provide fully visualized, data-rich interactive landscapes that accelerate and enhance drug discovery and commercialization, empowering users to be more innovative while supporting biopharma researchers in their search for the next breakthrough discovery.